IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / TRETINOIN 0.05% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Tretinoin; Levocetirizine Dihydrochloride; Imiquimod.
| Product ID | 72934-1126_87395273-37fc-7cef-e053-2991aa0a54c6 |
| NDC | 72934-1126 |
| Product Type | Human Prescription Drug |
| Proprietary Name | IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / TRETINOIN 0.05% |
| Generic Name | Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05% |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-05-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Sincerus Florida, LLC |
| Substance Name | TRETINOIN; LEVOCETIRIZINE DIHYDROCHLORIDE; IMIQUIMOD |
| Active Ingredient Strength | 0 g/100g; g/100g; g/100g |
| Pharm Classes | Retinoid [EPC],Retinoids [CS],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |